• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数<40%的中度缺血性二尖瓣反流患者在血运重建期间同时进行二尖瓣修复:一项单中心观察性研究。

Moderate Ischemic Mitral Regurgitation with Ejection Fraction <40% Undergoing Concomitant Mitral Valve Repair during Revascularization: A Single-Center Observational Study.

作者信息

Yang Ye, Liu Fangyu, Wang Yulin, Xia Limin, Wang Chunsheng, Ji Qiang

机构信息

Department of Cardiovascular Surgery, Zhongshan Hospital Fudan University, 200032 Shanghai, China.

Department of Cardiovascular Surgery, Xiamen Branch of Zhongshan Hospital Fudan University, 361015 Xiamen, Fujian, China.

出版信息

Rev Cardiovasc Med. 2023 Nov 24;24(11):328. doi: 10.31083/j.rcm2411328. eCollection 2023 Nov.

DOI:10.31083/j.rcm2411328
PMID:39076453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11272872/
Abstract

BACKGROUND

Numerous studies have examined the therapeutic effects of mitral valve repair during revascularization on moderate ischemic mitral regurgitation (IMR), as well as the incremental benefit of subvalvular repair alongside an annuloplasty ring. However, the impact of depressed left ventricular (LV) function on the surgical outcome of patients with moderate IMR has been rarely investigated. The aims of this single-center, retrospective, observational study were firstly to evaluate short- and medium-term outcomes in this patient group after undergoing mitral valve repair during revascularization, and secondly to assess the impact of depressed LV function on surgical outcomes.

METHODS

A total of 272 eligible patients who had moderate IMR and underwent concomitant mitral valve repair and revascularization from January 2010 to December 2017 were included in the study. These patients were categorized into different groups based on their ejection fraction (EF) levels: an EF 40% group (n = 90) and an EF 40% group (n = 182). The median time course of follow-up was 42 months and the shortest follow-up time was 30 months. This study compared in-hospital outcomes (major postoperative morbidity and surgical mortality) as well as midterm outcomes (moderate or more mitral regurgitation, all-cause mortality, and reoperation) of the two groups before and after propensity score (PS) matching (1:1).

RESULTS

No significant difference was observed in surgical mortality between groups (8.9% 3.3%, = 0.076). More patients in the EF 40% group developed low cardiac output (8.9% 2.7%, = 0.034) and prolonged ventilation (13.3% 5.5%, = 0.026) compared to the EF 40% group. Propensity score (PS) matching successfully established 82 patient pairs in a 1:1 ratio. No significance was discovered between the matched cohorts in terms of major postoperative morbidity and surgical mortality, except for prolonged ventilation. Conditional mixed-effects logistic regression analysis revealed that EF 40% had an independent impact on prolonged ventilation (odds ratio (OR) = 2.814, 95% CI 1.321-6.151, = 0.031), but was not an independent risk factor for surgical mortality (OR = 2.967, 95% CI 0.712-7.245, = 0.138) or other major postoperative morbidity. Furthermore, the two groups showed similar cumulative survival before (log-rank = 0.278) and after (stratified log-rank = 0.832) PS matching. regression analysis suggested that EF 40% was not related to mortality compared with EF 40% (PS-adjusted hazard ratio (HR) = 1.151, 95% CI 0.763-1.952, = 0.281).

CONCLUSIONS

Patients with moderate IMR and EF 40% shared similar midterm outcomes and surgical mortality to patients with moderate IMR and EF 40%, but received prolonged ventilation more often. Depressed LV function may be not associated with surgical or midterm mortality.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/184d5d0f094c/2153-8174-24-11-328-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/66f2740248ee/2153-8174-24-11-328-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/92a786f76f71/2153-8174-24-11-328-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/9136b9cbceb1/2153-8174-24-11-328-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/09b6d79fbb72/2153-8174-24-11-328-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/184d5d0f094c/2153-8174-24-11-328-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/66f2740248ee/2153-8174-24-11-328-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/92a786f76f71/2153-8174-24-11-328-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/9136b9cbceb1/2153-8174-24-11-328-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/09b6d79fbb72/2153-8174-24-11-328-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba9/11272872/184d5d0f094c/2153-8174-24-11-328-g5.jpg
摘要

背景

众多研究探讨了血运重建期间二尖瓣修复对中度缺血性二尖瓣反流(IMR)的治疗效果,以及瓣下修复联合瓣环成形环的额外获益。然而,左心室(LV)功能降低对中度IMR患者手术结局的影响鲜有研究。本单中心、回顾性、观察性研究的目的,一是评估该患者群体在血运重建期间接受二尖瓣修复后的短期和中期结局,二是评估LV功能降低对手术结局的影响。

方法

本研究纳入了2010年1月至2017年12月期间共272例患有中度IMR且同时接受二尖瓣修复和血运重建的符合条件的患者。这些患者根据其射血分数(EF)水平分为不同组:EF≥40%组(n = 90)和EF<40%组(n = 182)。随访的中位时间为42个月,最短随访时间为30个月。本研究比较了倾向评分(PS)匹配(1:1)前后两组的院内结局(术后主要并发症和手术死亡率)以及中期结局(中度或更严重的二尖瓣反流、全因死亡率和再次手术)。

结果

两组之间的手术死亡率无显著差异(8.9%对3.3%,P = 0.076)。与EF≥40%组相比,EF<40%组更多患者出现低心排血量(8.9%对2.7%,P = 0.034)和通气时间延长(13.3%对5.5%,P = 0.026)。倾向评分(PS)匹配成功以1:1的比例建立了82对患者。除通气时间延长外,匹配队列之间在术后主要并发症和手术死亡率方面未发现显著差异。条件混合效应逻辑回归分析显示,EF<4

相似文献

1
Moderate Ischemic Mitral Regurgitation with Ejection Fraction <40% Undergoing Concomitant Mitral Valve Repair during Revascularization: A Single-Center Observational Study.射血分数<40%的中度缺血性二尖瓣反流患者在血运重建期间同时进行二尖瓣修复:一项单中心观察性研究。
Rev Cardiovasc Med. 2023 Nov 24;24(11):328. doi: 10.31083/j.rcm2411328. eCollection 2023 Nov.
2
Patients over 70 years of age with moderate ischemic mitral regurgitation undergoing surgical revascularization plus mitral valve repair: insights from a single-center study of propensity-matched data.70岁以上患有中度缺血性二尖瓣反流且接受外科血运重建加二尖瓣修复术的患者:一项倾向匹配数据单中心研究的见解
Cardiovasc Diagn Ther. 2019 Dec;9(6):568-577. doi: 10.21037/cdt.2019.10.06.
3
Predictors of ischemic mitral regurgitation improvement after surgical revascularization plus mitral valve repair for moderate ischemic mitral regurgitation.中度缺血性二尖瓣反流患者接受手术血运重建加二尖瓣修复术后缺血性二尖瓣反流改善的预测因素。
J Card Surg. 2020 Mar;35(3):528-535. doi: 10.1111/jocs.14455. Epub 2020 Feb 4.
4
Mitral valve repair versus replacement in patients with ischaemic mitral regurgitation and depressed ejection fraction: risk factors for early and mid-term mortality†.缺血性二尖瓣反流伴射血分数降低患者二尖瓣修复与置换:早期和中期死亡率的危险因素†
Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):64-9. doi: 10.1093/icvts/ivu066. Epub 2014 Mar 27.
5
Elderly Patients with Moderate Chronic Ischemic Mitral Regurgitation: Coronary Artery Bypass Grafting Alone or Concomitant Mitral Annuloplasty?老年中度慢性缺血性二尖瓣反流患者:单纯冠状动脉旁路移植术还是联合二尖瓣环成形术?
Cardiol Res Pract. 2019 Dec 18;2019:1846904. doi: 10.1155/2019/1846904. eCollection 2019.
6
Late Durability of Mitral Repair for Ischemic Versus Nonischemic Functional Mitral Regurgitation.缺血性与非缺血性功能性二尖瓣反流患者二尖瓣修复术后的晚期耐久性。
Ann Thorac Surg. 2022 Oct;114(4):1358-1365. doi: 10.1016/j.athoracsur.2021.08.021. Epub 2021 Sep 20.
7
Echocardiographic Assessment of Ischaemic Mitral Regurgitation, Mechanism, Severity, Impact on Treatment Strategy and Long Term Outcome.缺血性二尖瓣反流的超声心动图评估:机制、严重程度、对治疗策略的影响及长期预后
Acta Inform Med. 2016 Jun;24(3):172-7. doi: 10.5455/aim.2016.24.172-177. Epub 2016 Jun 4.
8
Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.左心室与二尖瓣环不匹配对瓣环成形术后复发性缺血性二尖瓣反流的影响。
Circulation. 2016 Oct 25;134(17):1247-1256. doi: 10.1161/CIRCULATIONAHA.115.021014.
9
Should mild-to-moderate and moderate ischemic mitral regurgitation be corrected in patients with impaired left ventricular function undergoing simultaneous coronary revascularization?对于左心室功能受损且同时进行冠状动脉血运重建的患者,是否应纠正轻至中度和中度缺血性二尖瓣反流?
J Card Surg. 2001 Nov-Dec;16(6):473-83. doi: 10.1111/j.1540-8191.2001.tb00552.x.
10
Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair.缺血性二尖瓣反流:单纯血运重建与血运重建加二尖瓣修复
Ann Thorac Surg. 2005 Jun;79(6):1895-901. doi: 10.1016/j.athoracsur.2004.11.005.

本文引用的文献

1
Re-repair vs. Replacement for Failed Mitral Valve Repair: A Systemic Review and Meta-Analysis.二尖瓣修复失败后的再次修复与置换:系统评价与荟萃分析
Front Cardiovasc Med. 2022 Jun 14;9:868980. doi: 10.3389/fcvm.2022.868980. eCollection 2022.
2
The role of surgery for secondary mitral regurgitation and heart failure in the era of transcatheter mitral valve therapies.经导管二尖瓣治疗时代的手术在二尖瓣反流和心力衰竭二级预防中的作用。
Rev Cardiovasc Med. 2022 Mar 4;23(3):87. doi: 10.31083/j.rcm2303087.
3
New Perspective on Pathophysiology and Management of Functional Mitral Regurgitation.
功能性二尖瓣反流的病理生理学和治疗的新视角。
Trends Cardiovasc Med. 2023 Aug;33(6):386-392. doi: 10.1016/j.tcm.2022.03.001. Epub 2022 Mar 5.
4
Mitral Plasticity: The Way to Prevent the Burden of Ischemic Mitral Regurgitation?二尖瓣可塑性:预防缺血性二尖瓣反流负担的方法?
Front Cardiovasc Med. 2022 Jan 4;8:794574. doi: 10.3389/fcvm.2021.794574. eCollection 2021.
5
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
6
Mitral Valve Translocation: A Novel Operation for the Treatment of Secondary Mitral Regurgitation.二尖瓣转位:治疗继发性二尖瓣反流的一种新手术。
Ann Thorac Surg. 2021 Dec;112(6):1954-1961. doi: 10.1016/j.athoracsur.2021.07.043. Epub 2021 Aug 19.
7
Long-term outcomes of etiology specific annuloplasty ring repair of ischemic mitral regurgitation.缺血性二尖瓣反流病因特异性瓣环成形环修复的长期结果。
Ann Cardiothorac Surg. 2021 Jan;10(1):141-148. doi: 10.21037/acs-2020-mv-fs-0166.
8
Pathophysiology, Diagnosis, and New Therapeutic Approaches for Ischemic Mitral Regurgitation.缺血性二尖瓣反流的病理生理学、诊断和新的治疗方法。
Can J Cardiol. 2021 Jul;37(7):968-979. doi: 10.1016/j.cjca.2020.12.011. Epub 2021 May 14.
9
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
10
Multicenter experience: early outcome of mitral valve repair in patients with ischemic mitral regurgitation.多中心经验:缺血性二尖瓣反流患者二尖瓣修复的早期结果。
Asian Cardiovasc Thorac Ann. 2021 Feb;29(2):84-90. doi: 10.1177/0218492320970018. Epub 2020 Oct 25.